CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-25 | Hayden Michael R Director | Exercise or conversion · Stock Option (Right to Buy) | −8,230 | 0 | ||
| 2016-04-28 | TARNOW MICHAEL M Director | Exercise or conversion | +1,543 | $3.35 | $5K | 56,710 |
| 2016-04-28 | TARNOW MICHAEL M Director | Gift | −1,543 | 55,167 | ||
| 2016-04-28 | TARNOW MICHAEL M Director | Exercise or conversion · Stock Option (Right to Buy) | −1,543 | 0 | ||
| 2016-04-04 | WINQUIST RAYMOND Head, Translational Research | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2016-03-11 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2016-03-11 | GOLDBERG Y. PAUL VP, Clinical Development | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2016-03-11 | MORTIMER IAN CFO & COO | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2016-03-11 | COHEN CHARLES J. VP, Biology | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2016-03-11 | PIMSTONE SIMON N. President & CEO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2016-02-08 | EMPFIELD JAMES R. SVP, Drug Discovery | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2015-12-18 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2015-12-18 | PIMSTONE SIMON N. President & CEO | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2015-12-18 | MORTIMER IAN CFO & COO | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2015-12-18 | GOLDBERG Y. PAUL VP of Clinical Development | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2015-12-18 | COHEN CHARLES J. VP, Biology | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2015-12-16 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Exercise or conversion | +411 | $5.22 | $2K | 4,251 |
| 2015-12-16 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Shares withheld for taxes | −229 | $7.94 | $2K | 4,022 |
| 2015-12-16 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Exercise or conversion · Stock Option (Right to Buy) | −411 | 0 | ||
| 2015-12-11 | AZAB MOHAMMAD Director | Exercise or conversion | +2,469 | $5.22 | $13K | 4,938 |
Page 35 of 42 · 836 trades